Leadership/Faculty/Staff

Ms. Freeman works with principal investigators in the development and writing of new clinical research studies. She works to ensure accuracy, compliance with regulatory affairs, patient safety, feasibility of conducting the study in the neuro-oncology clinical setting, and consistency with the standards and requirements of the Duke Institutional Review Board (IRB) as well as the Cancer Protocol Committee (CPC).